[Thrombopenia during 5-ASA treatment (mesalazine and olsalazine)].
Benoit
R
R
Grobost
O
O
Bichoffe
A
A
Dol
L
L
D000293:Adolescent; D000636:Aminosalicylic Acids / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D019804:Mesalamine / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000139:chemically induced*
D000636:Aminosalicylic Acids; D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine; C032587:olsalazine
Thrombopénie au cours d'un traitement par 5-ASA (mésalazine puis olsalazine).